Cepheid
Jacobin Zorin currently serves as the Chief Privacy Officer at Cepheid, a role held since February 2014, which also includes responsibilities for Danaher's Diagnostic Platform companies following Cepheid's acquisition by Danaher Corporation in November 2016. Previous experience includes positions in the Legal and Finance Departments at LinkedIn from October 2011 to December 2013, and as Legal & Equity Programs Manager at Verigy until its acquisition by Advantest in 2011. Jacobin Zorin held project management and stock administration roles across several companies, including Stock & Option Solutions, Inc., Bookham, Inc., Credence Systems Corporation, NPTest, and Schlumberger. Additionally, early career experience includes a role as Director of Contracts at Tonbu, Inc., and as Senior Corporate Paralegal at Wilson Sonsini Goodrich & Rosati.
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.